AROICON 2018 SCIENTIFIC PROGRAMME. 29th November th Nov 2018 (Day 1)

Similar documents
DEPARTMENT OF ONCOLOGY ELECTIVE

Hall 406. Title: Opening & Keynote. Hall 405. Title: Treatment of node positive bladder. Hall 404

ACR TXIT TM EXAM OUTLINE

2. Occupancy rate of beds in the hospital: Occupancy rate of at least 60%

Steamboat Springs, Colorado. January 15-18, 2016

:00-13:00 Industry Satellite Symposium 1 Room A. 13:00-13:30 Welcome reception Hall 1. 13:30-13:45 Opening and welcome Room B

Oncology 101. Cancer Basics

Radiation Oncology Study Guide

National Cancer Registration and Analysis Service Short Report: Chemotherapy, Radiotherapy and Surgical Tumour Resections in England: (V2)

Medical Dosimetry Graduate Certificate Program IU Graduate School & The Department of Radiation Oncology IU Simon Cancer Center

NCCN GUIDELINES ON PROTON THERAPY (AS OF 4/23/18) BONE (Version , 03/28/18)

PRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019

Day-1 (3 rd November 2018)

FINAL SCIENTIFIC PROGRAMME

Clinical indications for positron emission tomography

Cancer Prevention & Control in Adolescent & Young Adult Survivors

NOSCAN CLINICAL MANAGEMENT GUIDELINE (CMG) AND NOSCAN CHEMOTHERAPY REVIEW (NCR) STATUS DOCUMENT May Status (G / A / R) Status (G / A / R)

肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部

High-Dose-Rate Orthogonal Intracavitary Brachytherapy with 9 Gy/Fraction in Locally Advanced Cervical Cancer: Is it Feasible??

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Identifying and counting people living with treatable but not curable cancer

16/12/14. Dear Colleagues

Unknown Primary Service for patients at Chesterfield Royal Hospital

Demands and Perspectives of Hadron Therapy

Module Guide 2017/18

RADIOTHERAPY IN BREAST CANCER :

Outcomes Report: Accountability Measures and Quality Improvements

Are the ESMO guidelines adapted to the elderly? D. Schrijvers, MD, PhD Ziekenhuisnetwerk Antwerpen(ZNA)-Middelheim Antwerp Belgium

Current Status and Future Medical Perspectives at MedAustron. U. Mock EBG MedAustron GmbH

Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute

CLIC Sargent Eligibility Criteria

CHEMO-RADIOTHERAPY FOR BLADDER CANCER. Dr Darren Mitchell Consultant Clinical Oncologist Northern Ireland Cancer Centre

Locally advanced disease & challenges in management

Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group

ENDPOINTS IN ONCOLOGY- HOW LONG WILL A CANCER PATIENT SURVIVE? DR GUNJAN BAIJAL CONSULTANT RADIATION ONCOLOGY MANIPAL GOA

University of Washington, Radiation Oncology Physics Residency Program. Medical Physics Site Specific Clinical Rotation

How a fully integrated Acute Oncology Service can benefit the busy medical unit

HALF. Who gets radiotherapy? Who gets radiotherapy? Half of all cancer patients get radiotherapy. By 1899 X rays were being used for cancer therapy

TENTATIVE SCIENTIFIC PROGRAM FOR OSSICON 2019

Cancer Waiting Times. 1 April Adjuvant Radical External Beam Radiotherapy Definitions. Version 1.0

Disclosures 5/13/2013. Principles and Practice of Radiation Oncology First Annual Cancer Rehabilitation Symposium May 31, 2013

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

Future of Radiation Therapy

Auditorium. Title: Welcome and Introduction by the Chairs Moderation: M. Pless, A. Cervantes ; Winterthur, CH, Valencia, ES

Cancer Awareness Talk ICPAK 2014

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.

Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC October 19-21, 2016

( ISNR 2009) PROGRAMME. ( Incorporating Ramachandra Advanced Interventional Neuroradiology (RAIN- 2009)

Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group

ADJUVANT CHEMOTHERAPY...

HEALTHCARE CLAIMS TRACKER A FOCUS ON ONCOLOGY CLAIMS. September 2018 For the period January 2017 December 2017

TUESDAY, 18th OCTOBER, 2016 / DAY -2

Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group

De-Escalate Trial for the Head and neck NSSG. Dr Eleanor Aynsley Consultant Clinical Oncologist

Enterprise Interest None

Outcomes Report: Accountability Measures and Quality Improvements

Vagina. 1. Introduction. 1.1 General Information and Aetiology

2016 CANCER PROGRAM REPORT. Bay Medical Sacred Heart Health System 615 North Bonita Avenue Panama City, FL

Gynecologic Cancer InterGroup Cervix Cancer Research Network. Management of Cervical Cancer in Resource Limited Settings.

Collection of Recorded Radiotherapy Seminars

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

PLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, Steamboat Springs, Colorado. January 12-15, 2018

Information Services Division NHS National Services Scotland

Hypofractionated RT in Cervix Cancer. Anuja Jhingran, MD

Cancer Program Report 2014

Guideline for the Follow-up of Patients with Gynaecological Malignancies

Research Strategy Committee Mitch Machtay, MD Deputy Group Chair, NRG RSC. NRG Semi-Annual Meeting Sunday, February 9, 2014

Breast Conservation Therapy

Nordic Society for Gynecological Oncology Advisory Board of Radiotherapy

Radiotherapy physics & Equipments

Combined drug and ionizing radiation: biological basis. Prof. Vincent GREGOIRE Université Catholique de Louvain, Cliniques Universitaires St-Luc

Trends in cancer incidence in South East England Henrik Møller and all staff at the Thames Cancer Registry, King s College London

28 th Annual Scientific Meeting

SKCC Protocol Review Committee New Study Application

Consensus and Controversies in Cancer of Prostate BASIS FOR FURHTER STUDIES. Luis A. Linares MD FACRO Medical Director

Cancer Facts & Figures for African Americans

Consultant Directory

SCOTTISH ONCOLOGY SUMMIT Double Tree by Hilton, Dunblane Hydro, Dunblane 1 st - 2 nd September 2017

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence

SAMO MASTERCLASS HEAD & NECK CANCER. Nicolas Mach, PD Geneva University Hospital

DOWNLOAD OR READ : COMBINED MODALITY THERAPY OF CENTRAL NERVOUS SYSTEM TUMORS PDF EBOOK EPUB MOBI

Head and Neck Service

MRI in Cervix and Endometrial Cancer

Checkpoint Regulators Cancer Immunotherapy takes centre stage. Dr Oliver Klein Department of Medical Oncology 02 May 2015

First, how does radiation work?

DELIVERING DISCOVERIES : EXPANDING THE REACH OF

Vaginal intraepithelial neoplasia

ESMO Clinical Practice Guidelines. ECCO GUIDELINES FORUM Brussels, November 27

Faster Cancer Treatment Indicators: Use cases

SCIENTIFIC PROGRAMME SNOLA UPDATE ON NEURO- ONCOLOGY th March

Macmillan Publications

Changing Paradigms in Radiotherapy

Head and Neck Service

Palliative care - the opportunities. Dr David Brooks Macmillan Consultant in Palliative Medicine Chesterfield Royal Hospital

SCIENTIFIC TIMETABLE SIOP 2015

Monitoring Patients Undergoing Cancer Therapy. By Timothy K. Egan

Stereotactic body radiation therapy in oligometastatic patient with lymph node recurrent prostate cancer: a single centre experience.

Immune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment

Inmunoterapia Desarrollo clínico: oportunidades entorno a SBRT

Transcription:

AROICON 2018 SCIENTIFIC PROGRAMME 29th November 2018 9.00am - 5.00pm Hall A (GV Raja Convention Centre, Level II): ICRO Pre- Conference Workshop- Imaging and Contouring 5.00-6.00pm ICRO General Body 30th Nov 2018 (Day 1) 9.00-9.30am Key Note I Reducing Morbidities of Treatment in Paediatric s: John A Kalapurakal, USA 9.30-10.30 am Hall A(GV Raja Convention Centre, level II) K A Dinshaw Oration Ben Slotman, Netherlands Hall A: GV Raja Convention Centre (Level II) Hall B: Hotel Uday Samudra (Lighthouse) Hall C: Uday Samudra (Bay)

10.30 am 1.00 pm Head & Neck Target Volume Delineation in Carcinoma Oropharynx-An Update Vincent Gregoire, France (25 min) New Head & Neck TNM classification and its Clinical Implications Kainicka lcessal T (25min) Status of Immunotherapy in Head and Neck Ruheena Mendes, UK (25min) 10.40 am 1.00 pm Genito Urinary Hypofractionation in Prostate David Dearnaley, UK (25min) Advances in the Management of Bladder Robert Huddart, UK (25min) Role of Nodal Irradiation in Ca Prostate Vedang Murthy (20min) 10.40am- 12.00pm Musculoskeletal Tumours Role of External Beam Radiation in Soft Tissue Sarcoma Aisha Miah, UK (25min) Newer Developments in the Systemic Treatment of STS - Goals and Options Sreejith G Nair (25min) Current status of De-intensification Protocols in HPV-positive Ca Oropharynx Sarbani Ghosh- Laskar (25 min) Image Guidance for Radiotherapy of Prostate Carcinoma Ajay Sandhu, USA (20min) Panel Discussion Challenges in Locally Advanced Head and Neck (50min) Moderator: Indranil Mallick Panellists: Rajesh Isiah, Kaushik Bhattacharya, Venugopal M, Pooja Nandwani Patel Debate: Surgery vsrt in Early Localized Ca Prostate(30min) Ginil Kumar Pvs V Kannan 1 1.00pm FRCR How to succeed? Tips for FRCR Examination Part I Rema Jyothirmayi (25min) Part II- TV Ajithkumar (25min) 1.00-1.30pm Hall A: Sponsored Symposium Role of Radiotherapy + Cetuximab in Advanced Head and Neck Squamous Cell Carcinoma

4.15pm Gastro- Intestinal Role of PRRT in Neuroendocrine tumours Sandip Basu (20min) SBRT in Hepatocellular Carcinoma Rojymon Jacob, USA(25min) Current Status of Neoadjuvant and Adjuvant Treatment of Carcinoma Rectum Najeeb Mohideen, USA (25min) 3.45pm CNS Tumour Evolution and Current Status of the Treatment of Low-Grade Gliomas Minesh P Mehta, USA (30min) What s New in the Management of Medulloblastoma TV Ajithkumar,UK (20min) Chemo-Radiation in Ca Oesophagus What has Changed? Shaleen Kumar (20min) Role of Definitive Surgery in Ca Oesophagus When and How? Chandramohan K (20min) Adjuvant Treatment of Ca Stomach Neeraj Rastogi (25min) SRS/WBRT in Metastatic Brain Disease Beena K (15min) Advanced Neuro-imaging to Measure Radiation Response Jona Hattangadi-Bluth, USA (20min) 4.00pm YROFProffered papers

3.45-4.45pm Brachy Therapy Role of Brachytherapy in Orbital Tumours Vijayanand Reddy (20min) Update of Brachytherapy in Soft Tissue Sarcomas Ashutosh Mukherji (20min) APBI In or Out? D N Sharma (20min) 4.00-5.00pm Proffered Papers: Head & Neck 4.15-5.00pm Sponsored Symposium EGFR M+ NSCLC Choosing the Best TKI for 1st Line Treatment ErbB Blockade in Squamous NSCLC & Experience of Afatinib in Second Line 4.45-5.30pm Sponsored Symposium Changing Paradigms in Frontline NSCLC Management 5.00-5.30pm Sponsored Symposium Immunotherapy After Chemoradiotherapy in Stage III NSCLC - A new Standard of Care? Strengthening the First-line Management of EGFR NSCLC 6.00-7.00pm 7.00 pm onwards Hall A: Inaugural Ceremony Cultural Programme & Dinner 1 st Dec 2018 (Day 2)

8.30-9.00am Key Note II Proton Beam Therapy: Minesh P Mehta, USA 9.00-9.30am Key Note III Radiotherapy in Head and Neck in the Next Decade: Vincent Gregoire, France 9.30-10.30 am 10.30 am - 1.00pm Breast BD Gupta Oration Brachytherapy - a Decaying or an Emerging Modality? Rajeev K Seam Hall A: GV Raja Convention Centre (Level II) Hall B: Hotel Uday Samudra (Lighthouse) Hall C: Uday Samudra (Bay) Fractionation Schedules in Breast Radiotherapy-Rationale John Yarnold, UK (25min) Respiratory Control during Breast Radiotherapy Sanjoy Chatterjee (20min) Controversies in Adjuvant Endocrine Therapy in Postmenopausal Patients-How Long is Long? Asha Arjunan (20min) 10.40 am 1.00 pm Lung NSCLC - Personalized Approach and Update on Systemic Chemotherapy in NSCLC Yoodhvir Singh Nagar, UK (25min) Chemo-RT in Stage IIIA NSCLC Ruheena Mendes, UK (25min) Sequencing of TKI in Lung Sajeed A (15min) 10.40am- 12.00pm Proffered Papers: CNS & GI s New Paradigms in the Anti-HER-2 Therapy in the Adjuvant &Neo Adjuvant Setting of Minimally Invasive Surgery in Early NSCLC

Breast Punita Lal (20min) Preoperative Breast Radiotherapy- A New Way Navita Somaiah, UK (20min) Panel Discussion Case Discussions in Early and Locally Advanced Breast (45min) Balasubramaniam KR (20min) Role of Immunotherapy in NSCLC Jayaprakash Madhavan (20min) Panel Discussion- Management of SCLC- What is New? (40min) 1 1.00pm Clinical Trials and Medical Writing Design and Conduct of Clinical Trials Minesh Mehta, USA (20min) How to Interpret a Paper Shyama Prem S (20min) Moderator: Suresh Kumar K Moderator: Roshni S Panellists: Paul Augustine, Anil Prahladan, Beela S Mathew, Anitha Mathews Panellists: JP Agarwal, CD Sivanandan, Sindhu Nair, Jubie Raj 1.00-1.40pm Hall A: Sponsored Symposium Phase III study of Nimotuzumab in Locally Advanced Head and Neck Panel Discussion: Redefining Management of Locally Advanced Head and Neck 5.00 pm Gynaecolo gical Adjuvant Treatment of Early Carcinoma Endometrium Rema Jyothirmayi, UK (25 min) Advances in Brachytherapy of Carcinoma Cervix Peter Hoskin, UK (25 min) Ultrasound-guided brachytherapy in Ca Cervix Kailash Narayan, Australia (20 min) 3.30pm Paediatric Update on Radiotherapy of Wilms tumour John A Kalapurakal, USA (25min) Outline in the Management of RMS Rakesh Kapoor (25min) Panel Discussion- Bone Tumours in Children (40min) 5.00pm Proffered Papers: Gynaec Breast Thorax Genito-urinary Miscellaneous

Incorporating ICRU 89 in Brachytherapy of Carcinoma Cervix Supriya Sastri (20min) Moderator: Arun Sankar Panellists: Subin Sugath, Selvamani B, Ahitagni Biswas, Priyakumari T BRCA Testing in Breast &Ovarian Linu Abraham Jacob (20 min) Panel Discussion Case Discussions in Gynaecological Malignancies (60min) Moderator: M G Janaki Panellists: Shalini Singh, Bhavana Rai, Sumod Mathew Koshy, Preethi T R

3.30-5.00pm Control Progress in Control in India G K Rath (20min) Financing Care in India: Lessons from Other Middle- Income Countries R Sankaranarayanan, France(20min) How Control can Contribute to Achieving the NCD Targets in 2025 Rachel Nugent, USA(20min) Role of Prevention in Control in India Gouravi Mishra(20min) 5.00-6.30pm 6.30-7.30pm 7.30pm onwards Hall A: Award Paper Session Hall A: General Body Meeting Cultural Programme & Dinner

2 nd Dec 2018 (Day 3) 8.30-9.00am Key Note IV Management of Locally Advanced Ca Prostate: David Dearnaley, UK 9.00-9.30am Key Note V Vaccines for Prevention of Cervical : R Sankaranarayanan, France 9.30-10.30 am 10.30-11.45 am Lymphoma Rengi Prasad Oration Is Artificial Intelligence going to replace an Oncologist in Future? Vivek Kaushal Hall A: GV Raja Convention Centre (Level II) Hall B: Hotel Uday Samudra (Lighthouse) Hall C: Uday Samudra (Bay) Tailored Treatment in the Management of The Basis of Fractionation in Hodgkin s Lymphoma Radiotherapy Peter Hoskin, UK (25 min) N Somaiah, UK (20min) Consolidation Radiotherapy in DLBCL Parag Sanghvi, USA (25min) Targeted Therapy in Hodgkin's Lymphoma - Current and Future Approaches Deepa Susan Philip (25min) 10.30- am- 12.30pm Frontiers in Oncology Altered fractionation in Head & Neck Sushmita Ghosal (20min) Genetic Screening in cancer Indian Scenario 10.30 am -12.30pm Radiation Physics New Technology in Indian Radiotherapy Departments Sunil Dutt Sharma (20min) Clinical Implementation of Pencil Beam Scanning Proton Therapy Dayananda SS (20min)

Rajiv Sarin (20min) 11.45am- 12.30pm Metastatic Role of Targeted therapy in Metastatic Colorectal Dipti Rani Samantha (15min) Systemic Therapy in Metastatic Kidney Ajayakumar T (15min) Radio-immunotherapy in Melanoma-A Way Forward? Roy Vergis, UK (20min) RT planning based on TCP/NTCP Manoj Kumar Gupta (20min) Tumour Immunology for the Clinician TS Ganesan (20min) Design, Development and Evaluation of Spacer Balloon in HDR Brachytherapy of Carcinoma Cervix Raghukumar P (20min) Imaging in RT planning Raghavendra Holla (20min) 12.30-1.00pm Hall A: Valedictory Function